You are here

  • Home
  • Archive
  • Volume 10, Issue 5
  • Response to: Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Zheng et al

Article metrics

Article menu

Download PDFPDF

Letter
Response to: Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Zheng et al

 

Online download statistics by month:

Online download statistics by month: May 2022 to August 2025

AbstractFullPdf
May 202202159
Jun 20220452122
Jul 2022019612
Aug 2022019316
Sep 2022020511
Oct 2022021517
Nov 202201599
Dec 202201465
Jan 2023014411
Feb 2023012615
Mar 202301056
Apr 20230954
May 202301189
Jun 202301030
Jul 202301078
Aug 2023011810
Sep 20230993
Oct 202301064
Nov 202301165
Dec 202301318
Jan 202401019
Feb 202401029
Mar 202409640
Apr 202409119
May 202401239
Jun 20240967
Jul 20240597
Aug 20240459
Sep 202403112
Oct 202403112
Nov 202405014
Dec 20240636
Jan 202503511
Feb 20250226
Mar 202503721
Apr 20250375
May 202503512
Jun 202504710
Jul 2025010
Aug 2025010
Total04252502